Halberd Co. (OTCMKTS:HALB) Short Interest Up 115.9% in August

Halberd Co. (OTCMKTS:HALB) was the recipient of a large increase in short interest in the month of August. As of August 15th, there was short interest totaling 19,000 shares, anincreaseof115.9% from the July 31st total of 8,800 shares. Based on an average daily volume of 1,764,300 shares, the short-interest ratio is presently 0.0 days. Based on an average daily volume of 1,764,300 shares, the short-interest ratio is presently 0.0 days.

Halberd Stock Down 15.4%

Halberd stock opened at $0.00 on Friday. Halberd has a 1-year low of $0.00 and a 1-year high of $0.01.

About Halberd

Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.